via Duke Medicine
Researchers hope to develop test that could detect early changes in blood flow to heart
A Duke Health pilot project suggests that in the near future, a blood test could show whether arteries carrying blood to the heart are narrow or blocked, a risk factor for heart disease.
According to the 40-person study published in the journal PLOS ONE, emergency patients who underwent a treadmill stress test and showed signs of decreased blood flow to the heart also had changes in five metabolites in their blood within two hours.
A control group of patients with normal stress tests did not show the same metabolite changes.
All study subjects had gone to the emergency department with symptoms of coronary disease, such as chest, jaw and shoulder pain.
The researchers hope a larger study could confirm that acute changes in these fatty acid and amino acid metabolites, which are energy sources for cells, could be an early biological indicator of restricted blood flow that could complement or even replace current tests.
“Cardiologists do a stress test to determine who’s at risk for having heart disease,” said lead author Alexander T. Limkakeng Jr., M.D., lead author of the study and an associate professor of emergency medicine at Duke. “It guides them on whether they need a more invasive study like a catheterization. Augmenting the imaging of a stress test with metabolite biomarkers could make that process more accurate or more efficient.”
Previous research has suggested that metabolites could indicate heart disease, but scientists have yet to uncover the specific metabolomic signature to look for. For the Duke study, scientists evaluated the presence of more than 60 chemicals or compounds in the blood to identify the five specific metabolites that appeared to change in patients with abnormal cardiac stress tests.
The researchers hope to begin a larger study to further test this approach to detecting coronary artery disease, they said.
Learn more: Blood Test for Specific Metabolites Could Reveal Blocked Arteries
The Latest on: Metabolite biomarkers
[google_news title=”” keyword=”metabolite biomarkers” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Metabolite biomarkers
- Potential to improve early cancer detection lands Elypta prize inspired by Star Trek creatoron March 30, 2023 at 8:42 am
The metabolism-based liquid biopsy improved on the ability of genomic tests to detect stage I cancers in a recent study.
- New longevity clinics use biomarkers to stop the clock on agingon March 30, 2023 at 8:00 am
RoseBar — a “longevity club” at the swank Six Senses Ibiza — offers services that may sound like they’re derived from science fiction. Guests can take DNA methylation tests to ...
- The Diagnostic Value of Biomarkers (SteatoTest) for the Prediction of Liver Steatosison March 29, 2023 at 5:00 pm
particularly in patients with metabolic risk factor. The objective of the current study was to create a new panel of biomarkers known as SteatoTest (ST) with sufficient predictive values for the ...
- InfanDx AG Revises Strategy and Broadens Diagnostics Pipeline for Child Healthon March 28, 2023 at 7:38 am
After promising top-line data for metabolic biomarkers, in-depth data analysis revealed BANON study results not generalizable to HIE patients in clinical routine. Development of HypoxE® test based ...
- InfanDx AG Revises Strategy and Broadens Diagnostics Pipeline for Child Healthon March 28, 2023 at 1:03 am
After promising top-line data for metabolic biomarkers, in-depth data analysis revealed BANON study results not generalizable to HIE patients in clinical routine. Development of HypoxE® test ...
- Metabolic Syndrome in APS Associated With Arterial Thrombosis, Cardiovascular Biomarkerson March 27, 2023 at 4:21 am
Researchers studied the prevalence of metabolic syndrome in patients with antiphospholipid syndrome as well as its association with clinical and laboratory features.
- Gut microbiota-derived biomarkers for identifying patients with fatty liver diseaseon March 21, 2023 at 10:21 am
A recent study at the University of Jyväskylä (Finland) compared the gut microbiota and gut-derived metabolites between healthy controls and individuals with fatty liver.
- Metabolic Biomarker Testing Market Size Report till 2028on March 16, 2023 at 10:28 am
Identify Target “Metabolic Biomarker Testing Market” Size 2023 After Metabolic Biomarker Testing Market Research, Businesses Should Identify Their Target Market. Which Can Increase the Chances ...
via Bing News
